We are live on ! Find out more
VIR icon

Vir Biotechnology
VIR

231 hedge funds and large institutions have $2.06B invested in Vir Biotechnology in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 83 increasing their positions, 75 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $11M | Put options by funds: $6.98M

35% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 26

11% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 75

3% more funds holding

Funds holding: 224 → 231 (+7)

1.58% more ownership

Funds ownership: 64.66% → 66.24% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less capital invested

Capital invested by funds: $2.18B → $2.06B (-$120M)

Holders
231
Holders Change
+7
Holders Change %
+3.13%
% of All Funds
3.68%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
35
Increased
83
Reduced
75
Closed
26
Calls
$11M
Puts
$6.98M
Net Calls
+$4.06M
Net Calls Change
+$1.52M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$43M
2
APM
Avidity Partners Management
Texas
+$20.2M
3
SI
Sofinnova Investments
California
+$16.8M
4
B
Braidwell
Connecticut
+$15.4M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$10.3M

Top Sellers

1
SIAU
SB Investment Advisers (UK)
United Kingdom
-$49.6M
2
Pacer Advisors
Pacer Advisors
Pennsylvania
-$28.1M
3
Morgan Stanley
Morgan Stanley
New York
-$14.8M
4
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
-$5.76M
5
Goldman Sachs
Goldman Sachs
New York
-$5.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
126
Martingale Asset Management
Massachusetts
$586K +$210K +8,208 +48%
GAM
127
Gotham Asset Management
New York
$569K -$595K -23,257 -49%
OPERF
128
Oregon Public Employees Retirement Fund
Oregon
$567K -$22.3K -870 -3%
AC
129
AXQ Capital
New Jersey
$555K +$610K +23,853 New
NL
130
NVWM LLC
Pennsylvania
$554K +$609K +23,797 New
State Board of Administration of Florida Retirement System
131
State Board of Administration of Florida Retirement System
Florida
$544K – – –
Los Angeles Capital Management
132
Los Angeles Capital Management
California
$541K -$1.01M -39,668 -63%
ZCM
133
Ziegler Capital Management
Illinois
$539K +$592K +23,152 New
Teacher Retirement System of Texas
134
Teacher Retirement System of Texas
Texas
$525K +$11.8K +463 +2%
Allianz Asset Management
135
Allianz Asset Management
Germany
$521K +$573K +22,394 New
TRSOTSOK
136
Teachers Retirement System of the State of Kentucky
Kentucky
$518K – – –
ASRS
137
Arizona State Retirement System
Arizona
$494K +$16.1K +629 +3%
PAM
138
Panagora Asset Management
Massachusetts
$488K +$536K +20,953 New
NYLIM
139
New York Life Investment Management
New York
$484K +$532K +20,793 New
TI
140
Tidal Investments
Wisconsin
$466K +$512K +20,015 New
ProShare Advisors
141
ProShare Advisors
Maryland
$462K -$98.2K -3,841 -16%
EFM
142
E Fund Management
China
$397K +$23.1K +903 +6%
MOACM
143
Mutual of America Capital Management
New York
$364K -$7.03K -275 -2%
GCM
144
Gallacher Capital Management
Colorado
$360K +$395K +15,456 New
Bank of Montreal
145
Bank of Montreal
Ontario, Canada
$337K +$62.8K +2,456 +24%
LTAS
146
Linden Thomas Advisory Services
North Carolina
$307K +$21K +821 +7%
Handelsbanken Fonder
147
Handelsbanken Fonder
Sweden
$305K +$335K +13,100 New
CSS
148
Cubist Systematic Strategies
Connecticut
$298K -$170K -6,642 -34%
HighTower Advisors
149
HighTower Advisors
Illinois
$290K -$148K -5,806 -32%
NAM
150
NorthCrest Asset Manangement
Minnesota
$286K +$23K +900 +8%
4 5
6
7 8

VIR Hedge Fund Activity: Q1 2023 in Review

231 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Vir Biotechnology (VIR) for Q1 2023, worth a combined $2.06B — down 5.5% from $2.18B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new VIR positions and 26 closed out — a net gain of 9 holders — while 83 added to existing stakes and 75 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $43M. The largest seller was SB Investment Advisers (UK), cutting an estimated $49.6M.

  • 231 institutional investors held Vir Biotechnology (VIR) as of Q1 2023, up from 224 in Q4 2022.
  • Funds reported $2.06B of Vir Biotechnology stock for Q1 2023, down 5.5% quarter-over-quarter.
  • 35 funds opened new Vir Biotechnology positions in Q1 2023 and 26 closed out, a net change of +9 holders.
  • The largest Vir Biotechnology buyer in Q1 2023 was Point72 Asset Management, an estimated $43M added.
  • The largest Vir Biotechnology seller in Q1 2023 was SB Investment Advisers (UK), an estimated $49.6M sold.

Based on aggregated 13F filings for Q1 2023.